USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
PRELUDE CORPORATION
Address:
26051 MERIT CIR, STE 102
LAGUNA HILLS, CA 92653-7008
Phone:
N/A
URL:
N/A
EIN:
190049538
DUNS:
962567793
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $273,920.00 1

Award List:

Multi-marker prognostic profile to predict invasive progression in DCIS patients

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$273,920.00
Agency:
HHS
Principal Investigator:
Steven P. Linke – 949-348-1188
Abstract:
DESCRIPTION (provided by applicant): Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer. The lesions are typically surgically removed. However, there is a risk of recurrence as another DCIS or as a more dangerous invasive cancer. If the DCIS is large, full mastectomy is used,… More